Targeting inflammation and gut microbiota with antibacterial therapy: Implications for central nervous system health
Ageing Research Reviews · 2024
DOI: 10.1016/j.arr.2024.102544 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Ageing Research Reviews, 2024. Verfasst von Jing Wei und 6 weiteren Autor:innen. Beteiligte Einrichtung: Eye School of Chengdu University of TCM, Key Laboratory of Sichuan Province Ophthalmopathy Prevention & Cure and Visual Function Protection with TCM …. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Central Nervous System, Gastrointestinal Microbiome, Inflammation. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 293 Literaturangaben. Gefördert von: Luzhou Science and Technology Bureau, Science and Technology Department of Sichuan Province, Liuzhou Science and Technology Project.
Abstract (Originalsprache)
The complex symbiotic relationship between inflammation, the gut microbiota, and the central nervous system (CNS) has become a pivotal focus of contemporary biomedical research. Inflammation, as a physiological defense mechanism, plays a dual role as both a protective and pathological factor, and is intricately associated with gut microbiota homeostasis, often termed the "second brain." The gutbrain axis (GBA) exemplifies this multifaceted interaction, where gut health exerts significantly regulatory effects on CNS functions. Antibacterial therapies represent both promising and challenging strategies for modulating inflammation and gut microbiota composition to confer CNS benefits. However, while such therapies may exert positive modulatory effects on the gut microbiota, they also carry the potential to disrupt microbial equilibrium, potentially exacerbating neurological dysfunction. Recent advances have provided critical insights into the therapeutic implications of antibacterial interventions; nevertheless, the application of these therapies in the context of CNS health warrants a judicious and evidence-based approach. As research progresses, deeper investigation into the microbial-neural interface is essential to fully realize the potential of therapies targeting inflammation and the gut microbiota for CNS health. Future efforts should focus on refining antibacterial interventions to modulate the gut microbiota while minimizing disruption to microbial balance, thereby reducing risks and enhancing efficacy in CNS-related conditions. In conclusion, despite challenges, a more comprehensive understanding of the GBA, along with precise modulation through targeted antibacterial therapies, offers significant promise for advancing CNS disorder treatment. Continued research in this area will lead to innovative interventions and improved patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Eye School of Chengdu University of TCM, Key Laboratory of Sichuan Province Ophthalmopathy Prevention & Cure and Visual Function Protection with TCM Laboratory, Retinal Image Technology and Chronic Vascular Disease Prev…
- Sichuan Key Medical Laboratory of New Drug Discovery and Drugability Evaluation, Luzhou Key Laboratory of Activity Screening and Druggability Evaluation for Chinese Materia Medica, Department of Cardiology, the Affiliat…
- Chongqing Key Laboratory of Sichuan-Chongqing Co-construction for Diagnosis and Treatment of Infectious Diseases Integrated Traditional Chinese and Western Medicine, Chongqing Traditional Chinese Medicine Hospital, Chon…
- School of Pharmaceutical Sciences, China-Pakistan International Science and Technology Innovation Cooperation Base for Ethnic Medicine Development in Hunan Province, Hunan University of Medicine, Huaihua 418000, China.…
Förderung
- Luzhou Science and Technology Bureau
- Science and Technology Department of Sichuan Province
- Liuzhou Science and Technology Project
- National Natural Science Foundation of China
- Chongqing Natural Science Foundation
Zitieren
APA
Wei, J., Liu, C., Qin, D., Ren, F., Duan, J., Chen, T., & Wu, A. (2024). Targeting inflammation and gut microbiota with antibacterial therapy: Implications for central nervous system health. Ageing Research Reviews. https://doi.org/10.1016/j.arr.2024.102544
Vancouver
Wei J, Liu C, Qin D, Ren F, Duan J, Chen T, et al. Targeting inflammation and gut microbiota with antibacterial therapy: Implications for central nervous system health. Ageing Research Reviews. 2024. doi:10.1016/j.arr.2024.102544
BibTeX
@article{Wei2024,
author = {Wei, Jing and Liu, Chunmeng and Qin, Dalian and Ren, Fang and Duan, Junguo and Chen, Ting and Wu, Anguo},
title = {Targeting inflammation and gut microbiota with antibacterial therapy: Implications for central nervous system health},
journal = {Ageing Research Reviews},
year = {2024},
doi = {10.1016/j.arr.2024.102544}
}
EUVIMED